Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Pharmacology & Therapeutics|January 1, 1991
Enhancement of anticancer agent activity by selective inhibition of rapidly proliferating tissues of the hostR L Stolfi, D S MartinCancer Treatment Reports|November 1, 1978
Therapeutic activity of maleic anhydride-vinyl ether copolymers against spontaneous, autochthonous murine mammary tumorsR L Stolfi, D S MartinChemotherapy|January 1, 1990
Chemotherapeutic activity of L-histidinol against spontaneous, autochthonous murine breast tumorsR L Stolfi, D S MartinJournal of Biological Response Modifiers|December 1, 1985
Modulation of chemotherapeutic drug activity with polyribonucleotides or with interferonR L Stolfi, D S MartinJournal of the National Cancer Institute|June 20, 1990
Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracilM A Moore, R L Stolfi, D S MartinJournal of the National Cancer Institute|June 1, 1988
Failure of high-dose leucovorin to improve therapy with the maximally tolerated dose of 5-fluorouracil: a murine study with clinical relevance?D S Martin, R L Stolfi, J R ColofioreCancer Research|January 1, 1987
Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumorsR L Stolfi, R C Sawyer, D S MartinCancer Chemotherapy and Pharmacology|January 1, 1989
Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridineD S Martin, R L Stolfi, R C SawyerCancer Research|June 1, 1986
Plasma levels of a viral protein during adjuvant treatment: reflection of murine mammary tumor status and therapeutic effectE M Ritzi, D S Martin, R L StolfiCancer Research|December 1, 1988
Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor systemR C Sawyer, R L Stolfi, D S MartinPageof 5